Cefazolin sodium contraindications: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
 
Line 4: Line 4:


==Contraindications==
==Contraindications==
Cefazolin for Injection, USP is contraindicated in patients who have a history of immediate hypersensitivity reactions (e.g., anaphylaxis, serious skin reactions) to cefazolin or the cephalosporin class of antibacterial drugs, penicillins or other beta-lactams [see Warnings and Precautions (5.1)].<ref>{{Cite web | last = |first =|title =http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50461slr139_ancef_lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50461slr139_ancef_lbl.pdf |publisher =|date = | accessdate = }}</ref>
 
Cefazolin for Injection, USP is contraindicated in patients who have a history of immediate [[hypersensitivity]] reactions (e.g., [[anaphylaxis]], serious skin reactions) to cefazolin or the cephalosporin class of antibacterial drugs, [[penicillins]] or other beta-lactams [see Warnings and Precautions (5.1)].<ref>{{Cite web | last = |first =|title =http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50461slr139_ancef_lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50461slr139_ancef_lbl.pdf |publisher =|date = | accessdate = }}</ref>


==References==
==References==

Latest revision as of 00:43, 6 January 2014

Cefazolin Sodium
CEFAZOLIN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Dosage and Administration
Compatibility, Reconstitution, and Stability
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

Cefazolin for Injection, USP is contraindicated in patients who have a history of immediate hypersensitivity reactions (e.g., anaphylaxis, serious skin reactions) to cefazolin or the cephalosporin class of antibacterial drugs, penicillins or other beta-lactams [see Warnings and Precautions (5.1)].[1]

References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50461slr139_ancef_lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.